Strategies for increasing the use of tranexamic acid in patients undergoing major surgery.

ABSTRACT: Tranexamic acid reduces major bleeding events in patients undergoing major surgery without increasing thromboembolic events. In October 2022, the Joint Royal Colleges Tranexamic Acid in Surgery Implementation Group issued recommendations for consideration of tranexamic acid use in all patients having inpatient surgery. National and local audit data shows that a significant portion of eligible patients do not receive tranexamic acid. We designed and implemented a quality improvement project to increase the use of tranexamic acid in patients undergoing major surgery (surgery with the potential for estimated blood loss > 500 ml). Data were collected on baseline tranexamic acid use and stakeholder-reported barriers to tranexamic acid use. This was used to design and implement a sequence of qua

SUBMITTER: Murphy L 

PROVIDER: S-EPMC11604225 | biostudies-literature | 2024 Jul-Dec

REPOSITORIES: biostudies-literature